BioSpace News Archive

Dr. Twitty brings over 20 years of experience in tumor immunology and cancer immunotherapy, including the discovery and development of OncoSec’s leading clinical immune monitoring and biomarker program.

Mr. Kung will help manage the development of PMV Pharma’s mutant p53 restoration drug pipeline, which got a boost this past February when the company completed a $74M series B financing round.

The patent encompasses Biocept’s proprietary “switch-blocker” technology, which enriches patient specimens for oncogene mutations of interest, resulting in ultra-high sensitivity and specificity for the detection of cancer-associated mutations.

Q Biomed announced today that all convertible notes and loans have been settled in full, including the $4M of convertible notes that had been issued pursuant to a Securities Purchase Agreement dated November 29, 2016.

Vomaris announced today breakthrough results of the first controlled, preclinical in vivo evidence on the anti-biofilm impact of the Company’s bioelectric antimicrobial technology.

This innovative technology, designed to improve processes in fertility laboratories, will be commercially available to IVF clinics in the U.S. in the first half of 2018.

The Bristol-Myers Squibb and Pfizer Alliance, the National Stroke Association and iHeartMedia today launched ‘Tune in to AFib, Take Note of Stroke Risk’ to educate the estimated nearly seven million Americans in 2017 living with atrial fibrillation (AFib) not caused by a heart valve problem about their increased risk of stroke.

Ocular Therapeutix announced that management will be hosting investor meetings at the Guggenheim Securities 5th Annual Boston Healthcare Conference on Wednesday, December 13, 2017 at The InterContinental Boston Hotel in Boston, Massachusetts.

Dec. 5, 2017 13:00 UTC Science 37 and Otsuka Pharmaceutical Collaborate to Advance Digital Health Innovation with Focus on Technology-Enabled Clinical Trials at Home New collaboration between the tech-enabled clinical research company and US mental health leader aims to transform clinical trials to accelerate patient access to innovative therapies PLAYA VISTA, Calif. & ROCKVILLE, Md.--( BUSINESS WIRE )-- Science 3

To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024.